RevOpsis Therapeutics: Funding, Investors & Team (Sep 2026)
RevOpsis Therapeutics is focused on tackling vision loss by leveraging its unique bispecific Surrobody platform to target a variety of eye-related conditions with potential therapeutic treatments. Established in 2022, the company is headquartered in Springfield, Illinois, USA.
RevOpsis Therapeutics has raised $18.7M across 4 funding rounds on record, the most recent a Seed announced in Sep 2025.
RevOpsis Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
RevOpsis Therapeutics Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
RevOpsis Therapeutics raised $7.9M in an undisclosed round announced in Aug 2023.
8 months later, a Seed of $9.0M was announced in Apr 2024.
6 months later, an undisclosed round of $1.8M was announced in Oct 2024.
11 months later, a Seed was announced in Sep 2025 with no disclosed amount.
RevOpsis Therapeutics Founders and Leadership Team
Contact details for the RevOpsis Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →RevOpsis Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like RevOpsis Therapeutics in Biotechnology and Springfield
Companies Similar to RevOpsis Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
RevOpsis Therapeutics Funding FAQs
What does RevOpsis Therapeutics do?
RevOpsis Therapeutics is focused on tackling vision loss by leveraging its unique bispecific Surrobody platform to target a variety of eye-related conditions with potential therapeutic treatments. Established in 2022, the company is headquartered in Springfield, Illinois, USA.
How much funding has RevOpsis Therapeutics raised?
RevOpsis Therapeutics has raised $18.7M across 4 rounds on record.
When did RevOpsis Therapeutics last raise funding?
RevOpsis Therapeutics' most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who founded RevOpsis Therapeutics?
FundedIQ lists Ramanath Bhandari (Founder) at RevOpsis Therapeutics.
Where is RevOpsis Therapeutics headquartered?
RevOpsis Therapeutics is based in Springfield, Illinois, United States.
How many employees does RevOpsis Therapeutics have?
RevOpsis Therapeutics is in the 1-10 employee band.
About FundedIQ's RevOpsis Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RevOpsis Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.